Key result
Transapical endocardial left ventricular lead implantation was feasible and provided effective cardiac resynchronization therapy with unchanged pacing parameters at 6 months.
Why the study?
Is transapical endocardial left ventricular lead implantation feasible for cardiac resynchronization therapy?
Population
1 patient requiring cardiac resynchronization therapy with extensive pericardial adhesions preventing…
Design
Case_report
Follow-up
6 months
Authors
Loading...
May offer alternative LV access in select CRT patients; hypothesis-generating and requires prospective validation before practice change.
Case Report (n=1)
Is transapical endocardial left ventricular lead implantation feasible for cardiac resynchronization therapy?
This case report demonstrates the first-in-human feasibility of transapical endocardial left ventricular lead implantation for cardiac resynchronization therapy.
Kassai et al. (2008) conducted a case report in Need for cardiac resynchronization therapy (n=1). Transapical endocardial left ventricular lead implantation was evaluated on Feasibility and effective CRT with unchanged pacing parameters. Transapical endocardial left ventricular lead implantation was feasible and provided effective cardiac resynchronization therapy with unchanged pacing parameters at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: